Brexpiprazole Demonstrates Positive Impact on Alzheimer Agitation, NDA Submission on the Horizon
Increased Risk for Neurodegenerative, Cerebrovascular Disorders Post COVID-19 Infection, Similar to Other Infections
Thalamic Volume Loss Reduced in Relapsing, Progressive Multiple Sclerosis Treated With Ocrelizumab
Next Steps in Expanding, Validating Capabilities of PrimSeq Digital Stroke Rehabilitation Tool: Heidi Schambra, MD